当前位置: 首页 SCI 期刊 医学 Neurology And Therapy(非官网)
Neurology And Therapy

Neurology And TherapySCISCIE

国际简称:NEUROL THER  参考译名:神经病学和治疗

  • 中科院分区

    3区

  • CiteScore分区

    Q2

  • JCR分区

    Q1

基本信息:
ISSN:2193-8253
E-ISSN:2193-6536
是否OA:开放
是否预警:否
TOP期刊:否
出版信息:
出版地区:ENGLAND
出版商:SPRINGER LONDON LTD
出版语言:English
出版周期:4 issues per year
研究方向:CLINICAL NEUROLOGY
评价信息:
CiteScore指数:5.4
SJR指数:1.042
SNIP指数:1.049
发文数据:
Gold OA文章占比:99.31%
研究类文章占比:79.25%
年发文量:53
自引率:0.0466...
开源占比:0.9825
出版撤稿占比:0
出版国人文章占比:0
OA被引用占比:1
英文简介 期刊介绍 CiteScore数据 中科院SCI分区 JCR分区 发文数据 常见问题

英文简介Neurology And Therapy期刊介绍

Aims and Scope

Neurology and Therapy aims to provide reliable and inclusive, rapid publication for all therapy related research for neurological indications, supporting the timely dissemination of research with a global reach, to help advance scientific discovery and support clinical practice.

Neurology and Therapy is an international, open access, peer reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world and health outcomes research around the discovery, development, and use of neurological and psychiatric therapies, (also covering surgery and devices). Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also welcomed.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, case reports, trial designs, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Neurology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

Rapid Publication

The journal’s rapid publication timelines aim for a peer review decision within 2 weeks of submission. If an article is accepted, it will be published online 3-4 weeks from acceptance. These rapid timelines are achieved through the combination of a dedicated in-house editorial team, who closely manage article workflow, and an extensive Editorial and Advisory Board who assist with rapid peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model, this allows for the rapid and efficient communication of the latest research and reviews to support scientific discovery and clinical practice.

Open Access

All articles published by Neurology and Therapy are open access.

Personal Service

The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning that authors will always have a personal point of contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. We also encourage pre-submission enquiries and are always happy to provide a confidential assessment of manuscripts.

Digital Features and Plain Language Summaries

Neurology and Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’.

For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/

Publication Fees

Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5250/$6000/£4300. The journal will consider fee discounts and waivers for developing countries and this is decided on a case-by-case basis.

Peer Review Process

Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials and Letters which are generally reviewed by one member of the Editorial Board. Where reviews conflict, an Editorial Board Member will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed. Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised, it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor, and authors are welcome to make rebuttals against individual reviewer comments, if appropriate.

Preprints

We encourage posting of preprints of primary research manuscripts on preprint servers, authors' or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals.

Please see here for further information on preprint sharing: https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550

Copyright

Neurology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

Contact

For more information about the journal, including pre-submission enquiries, please contact managing editor Lydia Alborn at lydia.alborn@springer.com.

期刊简介Neurology And Therapy期刊介绍

《Neurology And Therapy》是一本医学优秀杂志。致力于发表原创科学研究结果,并为医学各个领域的原创研究提供一个展示平台,以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述,从广泛的视角提供当前感兴趣的研究主题的新见解,或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年被列入预警期刊名单,目前已被权威数据库SCI、SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

Cite Score数据Neurology And Therapy Cite Score数据

  • CiteScore:5.4
  • SJR:1.042
  • SNIP:1.049
学科类别 分区 排名 百分位
大类:Medicine 小类:Neurology (clinical) Q2 134 / 400

66%

大类:Medicine 小类:Neurology Q2 67 / 192

65%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Neurology And Therapy 中科院分区

中科院 2023年12月升级版 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 3区 CLINICAL NEUROLOGY 临床神经病学 3区
中科院 2022年12月升级版 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 3区 CLINICAL NEUROLOGY 临床神经病学 3区
中科院 2021年12月旧的升级版 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 3区 CLINICAL NEUROLOGY 临床神经病学 4区
中科院 2021年12月基础版 综述期刊:是 Top期刊:是
大类学科 分区 小类学科 分区
医学 2区 CLINICAL NEUROLOGY 临床神经病学 2区
中科院 2021年12月升级版 综述期刊:是 Top期刊:是
大类学科 分区 小类学科 分区
医学 3区 CLINICAL NEUROLOGY 临床神经病学 4区

中科院分区表 是以客观数据为基础,运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据,得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次,类似于“优、良、及格”等。最开始,这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Neurology And Therapy JCR分区

2022-2023 年最新版
JCR 分区等级 JCR 学科 JCR 分区
Q1 CLINICAL NEUROLOGY Q2

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2019-2021 年国家/地区发文量统计
  • 国家/地区数量
  • USA73
  • England26
  • Italy18
  • GERMANY (FED REP GER)17
  • Canada12
  • Switzerland11
  • Brazil7
  • France7
  • Sweden7
  • Japan6

本刊中国学者近年发表论文

  • 1、Optimizing The Timing of Stereotactic Minimally Invasive Drainage for Hypertensive Intracerebral Hemorrhag
  • 2、Brain Complexity Predicts Response to Adrenocorticotropic Hormone in Infantile Epileptic Spasms Syndrome: A Retrospective Stud
  • 3、Association between Serum Amyloid A Level and White Matter Hyperintensity Burden: a Cross-Sectional Analysis in Patients with Acute Ischemic Strok
  • 4、Non-drug Therapies for Alzheimer's Disease: A Revie
  • 5、Effect of ANKK1 Polymorphisms on Serum Valproic Acid Concentration in Chinese Han Adult Patients in the Early Postoperative Perio
  • 6、Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subject
  • 7、Optic Nerve Sheath Fenestration for Progressive Visual Loss in Cerebral Venous Sinus Thrombosis: A Long-Term Retrospective Observational Stud
  • 8、The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atroph

投稿常见问题

通讯方式:236 GRAYS INN RD, 6TH FLOOR, LONDON, ENGLAND, WC1X 8HL。